Literature DB >> 31624196

Mobilizing unconventional T cells.

Tom H M Ottenhoff1, Simone A Joosten2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31624196      PMCID: PMC6842658          DOI: 10.1126/science.aay7079

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  15 in total

1.  Antigen Processing in the Endoplasmic Reticulum Is Monitored by Semi-Invariant αβ TCRs Specific for a Conserved Peptide-Qa-1b MHC Class Ib Ligand.

Authors:  Jian Guan; Soo Jung Yang; Federico Gonzalez; Yuxin Yin; Nilabh Shastri
Journal:  J Immunol       Date:  2017-01-20       Impact factor: 5.422

2.  Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Pascale C van Weeren; Fatima Kazi; Annemieke Geluk; Nigel D L Savage; Jan W Drijfhout; Darren R Flower; Willem A Hanekom; Michèl R Klein; Tom H M Ottenhoff
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

3.  Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine.

Authors:  Scott G Hansen; Daniel E Zak; Guangwu Xu; Julia C Ford; Emily E Marshall; Daniel Malouli; Roxanne M Gilbride; Colette M Hughes; Abigail B Ventura; Emily Ainslie; Kurt T Randall; Andrea N Selseth; Parker Rundstrom; Lauren Herlache; Matthew S Lewis; Haesun Park; Shannon L Planer; John M Turner; Miranda Fischer; Christina Armstrong; Robert C Zweig; Joseph Valvo; Jackie M Braun; Smitha Shankar; Lenette Lu; Andrew W Sylwester; Alfred W Legasse; Martin Messerle; Michael A Jarvis; Lynn M Amon; Alan Aderem; Galit Alter; Dominick J Laddy; Michele Stone; Aurelio Bonavia; Thomas G Evans; Michael K Axthelm; Klaus Früh; Paul T Edlefsen; Louis J Picker
Journal:  Nat Med       Date:  2018-01-15       Impact factor: 53.440

4.  A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors.

Authors:  Lucy C Sullivan; Nicholas G Walpole; Carine Farenc; Gabriella Pietra; Matthew J W Sum; Craig S Clements; Eleanor J Lee; Travis Beddoe; Michela Falco; Maria Cristina Mingari; Lorenzo Moretta; Stephanie Gras; Jamie Rossjohn; Andrew G Brooks
Journal:  J Biol Chem       Date:  2017-09-25       Impact factor: 5.157

5.  Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset.

Authors:  Krista E van Meijgaarden; Mariëlle C Haks; Nadia Caccamo; Francesco Dieli; Tom H M Ottenhoff; Simone A Joosten
Journal:  PLoS Pathog       Date:  2015-03-24       Impact factor: 6.823

6.  New Genome-Wide Algorithm Identifies Novel In-Vivo Expressed Mycobacterium Tuberculosis Antigens Inducing Human T-Cell Responses with Classical and Unconventional Cytokine Profiles.

Authors:  Mariateresa Coppola; Krista E van Meijgaarden; Kees L M C Franken; Susanna Commandeur; Gregory Dolganov; Igor Kramnik; Gary K Schoolnik; Inaki Comas; Ole Lund; Corine Prins; Susan J F van den Eeden; Gro E Korsvold; Fredrik Oftung; Annemieke Geluk; Tom H M Ottenhoff
Journal:  Sci Rep       Date:  2016-11-28       Impact factor: 4.379

Review 7.  Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.

Authors:  Pascale André; Caroline Denis; Caroline Soulas; Clarisse Bourbon-Caillet; Julie Lopez; Thomas Arnoux; Mathieu Bléry; Cécile Bonnafous; Laurent Gauthier; Ariane Morel; Benjamin Rossi; Romain Remark; Violette Breso; Elodie Bonnet; Guillaume Habif; Sophie Guia; Ana Ines Lalanne; Caroline Hoffmann; Olivier Lantz; Jérôme Fayette; Agnès Boyer-Chammard; Robert Zerbib; Pierre Dodion; Hormas Ghadially; Maria Jure-Kunkel; Yannis Morel; Ronald Herbst; Emilie Narni-Mancinelli; Roger B Cohen; Eric Vivier
Journal:  Cell       Date:  2018-11-29       Impact factor: 41.582

8.  The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects.

Authors:  Cláudia C Oliveira; Peter A van Veelen; Bianca Querido; Arnoud de Ru; Marjolein Sluijter; Sandra Laban; Jan W Drijfhout; Sjoerd H van der Burg; Rienk Offringa; Thorbald van Hall
Journal:  J Exp Med       Date:  2009-12-28       Impact factor: 14.307

9.  Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding.

Authors:  Lucy C Walters; Karl Harlos; Simon Brackenridge; Daniel Rozbesky; Jordan R Barrett; Vitul Jain; Thomas S Walter; Chris A O'Callaghan; Persephone Borrow; Mireille Toebes; Scott G Hansen; Jonah B Sacha; Shaheed Abdulhaqq; Justin M Greene; Klaus Früh; Emily Marshall; Louis J Picker; E Yvonne Jones; Andrew J McMichael; Geraldine M Gillespie
Journal:  Nat Commun       Date:  2018-08-07       Impact factor: 14.919

10.  Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.

Authors:  Scott G Hansen; Helen L Wu; Benjamin J Burwitz; Colette M Hughes; Katherine B Hammond; Abigail B Ventura; Jason S Reed; Roxanne M Gilbride; Emily Ainslie; David W Morrow; Julia C Ford; Andrea N Selseth; Reesab Pathak; Daniel Malouli; Alfred W Legasse; Michael K Axthelm; Jay A Nelson; Geraldine M Gillespie; Lucy C Walters; Simon Brackenridge; Hannah R Sharpe; César A López; Klaus Früh; Bette T Korber; Andrew J McMichael; S Gnanakaran; Jonah B Sacha; Louis J Picker
Journal:  Science       Date:  2016-01-21       Impact factor: 47.728

View more
  6 in total

1.  Identification of HLA-E Binding Mycobacterium tuberculosis-Derived Epitopes through Improved Prediction Models.

Authors:  Paula Ruibal; Kees L M C Franken; Krista E van Meijgaarden; Marjolein van Wolfswinkel; Ian Derksen; Ferenc A Scheeren; George M C Janssen; Peter A van Veelen; Charlotte Sarfas; Andrew D White; Sally A Sharpe; Fabrizio Palmieri; Linda Petrone; Delia Goletti; Thomas Abeel; Tom H M Ottenhoff; Simone A Joosten
Journal:  J Immunol       Date:  2022-09-12       Impact factor: 5.426

Review 2.  Antigen presentation by MHC-E: a putative target for vaccination?

Authors:  Linda Voogd; Paula Ruibal; Tom H M Ottenhoff; Simone A Joosten
Journal:  Trends Immunol       Date:  2022-03-31       Impact factor: 19.709

3.  Peptide Binding to HLA-E Molecules in Humans, Nonhuman Primates, and Mice Reveals Unique Binding Peptides but Remarkably Conserved Anchor Residues.

Authors:  Paula Ruibal; Kees L M C Franken; Krista E van Meijgaarden; Joeri J F van Loon; Dirk van der Steen; Mirjam H M Heemskerk; Tom H M Ottenhoff; Simone A Joosten
Journal:  J Immunol       Date:  2020-10-05       Impact factor: 5.422

4.  Targeting Unconventional T Cells for Vaccination against Tuberculosis.

Authors:  Katalin A Wilkinson; Maddalena Cerrone
Journal:  Am J Respir Cell Mol Biol       Date:  2020-04       Impact factor: 6.914

Review 5.  The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy.

Authors:  Akhil Shukla; Maryse Cloutier; Madanraj Appiya Santharam; Sheela Ramanathan; Subburaj Ilangumaran
Journal:  Int J Mol Sci       Date:  2021-02-17       Impact factor: 5.923

Review 6.  Deregulation of HLA-I in cancer and its central importance for immunotherapy.

Authors:  Ahmet Hazini; Kerry Fisher; Len Seymour
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 13.751

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.